Oculis Holding has concluded subject enrolment for the Phase III DIAMOND-1 and DIAMOND-2 clinical trials of OCS-01 eye drops ...

A new drug application has been submitted for Brimochol™ PF (Tenpoint Therapeutics Ltd.) for the treatment of presbyopia.

Most studies on the combination eye drop brinzolamide and brimonidine (Symbrinza) used the drug three times daily.

Serious side effects from H2 blockers are rare. Like PPIs, they can sometimes cause low B12 levels. Headaches and agitation ...

The patient information guide from Simbrinza says to use it no more than twice a day. I talked to my doctor about this last ...

Tenpoint Therapeutics submitted a new drug application to the FDA for Brimochol PF, an eye drop for presbyopia treatment, ...

Robert F. Kennedy Jr. and the so-called Department of Government Efficiency terminated thousands of experienced public health ...

Drug-loaded contact lenses for glaucoma treatment appear to demonstrate safety and effectiveness in reducing IOP, according ...

Akums has launched a pioneering treatment for glaucoma in India. The new eye drops combines two treatments in one drop, ...

Twenty-four-hour average ambulatory blood pressure, the trial's primary endpoint, dropped by 7.9 mm Hg and 6.5 mm Hg more than placebo in the two study groups that received the drug (with one ...

KWONG: Across the country, the number of overdose deaths has continued to drop to this day. MANN: This is a science-fiction level event, like never before in the history of America's drug crisis.